Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment Monitoring

被引:117
作者
McMahon, James H. [1 ,3 ]
Jordan, Michael R. [2 ,6 ]
Kelley, Karen [6 ]
Bertagnolio, Silvia [6 ]
Hong, Steven Y. [1 ]
Wanke, Christine A. [1 ]
Lewin, Sharon R. [3 ,4 ,5 ]
Elliott, Julian H. [3 ,4 ,5 ]
机构
[1] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia
[4] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[5] Burnet Inst, Melbourne, Vic, Australia
[6] WHO, CH-1211 Geneva, Switzerland
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; PREDICT VIROLOGICAL FAILURE; PROTEASE INHIBITOR THERAPY; VIRAL LOAD RESPONSE; HIV-1-INFECTED PATIENTS; DRUG-RESISTANCE; AFRICAN ADULTS; REFILL MEASURE; CD4; COUNT;
D O I
10.1093/cid/ciq167
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Prescription or pill-based methods for estimating adherence to antiretroviral therapy (ART), pharmacy adherence measures (PAMs), are objective estimates calculated from routinely collected pharmacy data. We conducted a literature review to evaluate PAMs, including their association with virological and other clinical outcomes, their efficacy compared with other adherence measures, and factors to consider when selecting a PAM to monitor adherence. PAMs were classified into 3 categories: medication possession ratio (MPR), pill count (PC), and pill pick-up (PPU). Data exist to recommend PAMs over self-reported adherence. PAMs consistently predicted patient outcomes, but additional studies are needed to determine the most predictive PAM parameters. Current evidence suggests that shorter duration of adherence assessment (<= 6 months) and use of PAMs to predict future outcomes may be less accurate. PAMs which incorporate the number of days for which ART was prescribed without the counting of remnant pills, are reasonable minimum-resource methods to assess adherence to ART.
引用
收藏
页码:493 / 506
页数:14
相关论文
共 56 条
[1]   Assessment of adherence to triple antiretroviral treatment including indinavir: Role of the determination of plasma levels of indinavir [J].
Alcoba, M ;
Cuevas, TJ ;
Perez-Simon, MR ;
Mostaza, TL ;
Ortega, L ;
de Urbina, JO ;
Carro, JA ;
Raya, T ;
Abad, M ;
Martin, V .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) :253-258
[2]   Preventing HIV antiretroviral resistance through better monitoring of treatment adherence [J].
Bangsberg, David R. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 :S272-S278
[3]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[4]   Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness [J].
Bangsberg, DR ;
Acosta, EP ;
Gupta, R ;
Guzman, D ;
Riley, ED ;
Harrigan, PR ;
Parkin, N ;
Deeks, SG .
AIDS, 2006, 20 (02) :223-231
[5]   Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana [J].
Bisson, Gregory P. ;
Rowh, Adam ;
Weinstein, Rachel ;
Gaolathe, Tendani ;
Frank, Ian ;
Gross, Robert .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (01) :107-110
[6]   Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy [J].
Bisson, Gregory P. ;
Gross, Robert ;
Bellamy, Scarlett ;
Chittams, Jesse ;
Hislop, Michael ;
Regensberg, Leon ;
Frank, Ian ;
Maartens, Gary ;
Nachega, Jean B. .
PLOS MEDICINE, 2008, 5 (05) :777-789
[7]   Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies [J].
Braithwaite, R. Scott ;
Kozal, Michael J. ;
Chang, Chung Chou H. ;
Roberts, Mark S. ;
Fultz, Shawn L. ;
Goetz, Matthew Bidwell ;
Gibert, Cynthia ;
Rodriguez-Barradas, Maria ;
Mole, Larry ;
Justice, Amy C. .
AIDS, 2007, 21 (12) :1579-1589
[8]  
Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2
[9]   Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression [J].
Cambiano, V. ;
Lampe, F. C. ;
Rodger, A. J. ;
Smith, C. J. ;
Geretti, A. M. ;
Lodwick, R. K. ;
Holloway, J. ;
Johnson, M. ;
Phillips, A. N. .
HIV MEDICINE, 2010, 11 (03) :216-224
[10]   Role of clinical pharmacists in outpatient HIV clinics [J].
Cantwell-McNelis, K ;
James, CW .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (05) :447-452